R. Rohrer

发表

Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant.

F. Delmonico, R. Freeman, S. Supran, 2001, Transplantation proceedings.

Granular cell tumor with cirrhosis and transplantation.

R. Freeman, R. Fairchild, R. Rohrer, 1999, Transplantation.

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients

D. Snydman, M. Falagas, R. Freeman, 1996 .

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.

D. Snydman, M. Falagas, R. Freeman, 2001, Transplantation proceedings.

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

R. Wiesner, J. Griffith, D. Snydman, 1998, Transplantation.

Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.

D. Snydman, M. Falagas, R. Freeman, 1998, The Journal of infectious diseases.

Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients.

J. Griffith, D. Snydman, M. Falagas, 1997, Transplantation.

Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Freeman, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Results of an Organ Procurement Organization Effort to Increase Utilization of Donors after Cardiac Death

Scott R. Johnson, F. Delmonico, J. Whiting, 2006, Transplantation.

Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.

D. Snydman, R. Freeman, R. Kirkman, 1993, Transplantation proceedings.

Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.

J. Griffith, D. Snydman, M. Falagas, 1997, Clinical transplantation.

Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group.

D. Snydman, M. Falagas, R. Freeman, 1996, Transplantation.